CME Group (NASDAQ:CME) Given New $347.00 Price Target at Rothschild & Co Redburn

CME Group (NASDAQ:CME) had its target price boosted by stock analysts at Rothschild & Co Redburn from $333.00 to $347.00 in a report issued on Thursday,MarketScreener reports. The firm currently has a “neutral” rating on the financial services provider’s stock. Rothschild & Co Redburn’s target price suggests a potential upside of 14.40% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on CME. The Goldman Sachs Group boosted their target price on shares of CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a research report on Monday, February 9th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, March 5th. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Finally, Piper Sandler raised their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $303.53.

CME Group Stock Performance

NASDAQ:CME opened at $303.33 on Thursday. The stock has a market cap of $109.38 billion, a P/E ratio of 27.18, a PEG ratio of 3.31 and a beta of 0.24. The stock has a 50 day simple moving average of $294.21 and a 200 day simple moving average of $278.44. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group has a 1-year low of $248.53 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.52 EPS. Research analysts anticipate that CME Group will post 10.49 earnings per share for the current year.

Insider Activity

In other news, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. The trade was a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 5,248 shares of company stock valued at $1,616,700. Corporate insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CME. Caldwell Trust Co grew its position in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after buying an additional 50 shares during the last quarter. Asset Dedication LLC raised its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group in the third quarter worth approximately $27,000. FNY Investment Advisers LLC bought a new stake in CME Group in the fourth quarter valued at approximately $27,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in CME Group in the fourth quarter valued at approximately $27,000. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.